- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: CYP1A1
Gene name: cytochrome P450, family 1, subfamily A, polypeptide 1
HGNC ID: 2595
Synonyms: P450DX, P1-450, P450-C, CP11
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | CD8A | 1 hits |
| 2 | CYP1B1 | 1 hits |
| 3 | CYP2B6 | 1 hits |
| 4 | CYP2C19 | 1 hits |
| 5 | FABP1 | 1 hits |
| 6 | SLC5A1 | 1 hits |
| 7 | TBXAS1 | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 2143687 | In a comparison of patients receiving MCV alone to MCV + CYP 300 mg/m2 phenotypic analysis of lymphocyte subsets showed significant (P = 0.03) reduction in the CD8+CD11B+ (suppressor) cells of the latter group. |
| 2 | 15207781 | Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1. |
| 3 | 15207781 | Cytochrome P450 CYP1B1 (CYP1B1) is a member of the CYP1 P450 enzyme family that is overexpressed in a variety of solid tumors. |
| 4 | 15207781 | Immunization of HLA-A2/Kb transgenic mice with human CYP1B1 encoding plasmid DNA formulated in poly(lactide-co-glycolide) (PLG) microparticles elicits CD8+ T cells that respond to human CYP1B1-positive target cells. |
| 5 | 15694700 | Drug biotransformations are controlled in the body by tissue-differentiated choice of a selection of the induced and constitutive 57 isoforms of the human cytochromes P450 (CYP). |
| 6 | 16555997 | Cytochrome P450 1B1: a novel anticancer therapeutic target. |
| 7 | 16555997 | Cytochrome P450 (CYP)1B1 is overexpressed in tumor cells and is also recognized as a biomarker of the tumor phenotype. |
| 8 | 24990552 | Coleus forskohlii extract attenuates the hypoglycemic effect of tolbutamide in vivo via a hepatic cytochrome P450-mediated mechanism. |
| 9 | 24990552 | In particular, increases in activity and protein expression were noted for the CYP2B, CYP2C, and CYP3A subtypes. |
| 10 | 24990552 | These results indicate that CFE induced hepatic CYPs in rats and attenuated the hypoglycemic action of tolbutamide via a hepatic CYP2C-mediated mechanism. |
| 11 | 25049616 | LPS and CYP increased intestinal enzyme activity, relative expression of SGLT-1, CaBP-D28k and L-FABP mRNAs (p<0.05). |